TissGeneSummary for XRCC4 |
Gene summary |
Basic gene information | Gene symbol | XRCC4 |
Gene name | X-ray repair complementing defective repair in Chinese hamster cells 4 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 5q14.2 | |
Type of gene | protein-coding | |
RefGenes | NM_003401.3, NM_022406.2,NM_022550.2, | |
Description | DNA repair protein XRCC4X-ray repair cross-complementing protein 4X-ray repair, complementing defective, repair in Chinese hamster | |
Modification date | 20141222 | |
dbXrefs | MIM : 194363 | |
HGNC : HGNC | ||
Ensembl : ENSG00000152422 | ||
HPRD : 15951 | ||
Vega : OTTHUMG00000131319 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_XRCC4 | |
BioGPS: 7518 | ||
Pathway | NCI Pathway Interaction Database: XRCC4 | |
KEGG: XRCC4 | ||
REACTOME: XRCC4 | ||
Pathway Commons: XRCC4 | ||
Context | iHOP: XRCC4 | |
ligand binding site mutation search in PubMed: XRCC4 | ||
UCL Cancer Institute: XRCC4 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Bone marrowTestis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LAMLTGCT | |
Reference showing the relevant tissue of XRCC4 | ||
Description by TissGene annotations | Cancer gene TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006302 | double-strand break repair | 9242410 | GO:0006303 | double-strand break repair via nonhomologous end joining | 12517771 | GO:0010165 | response to X-ray | 9242410 | GO:0051103 | DNA ligation involved in DNA repair | 12517771 | GO:0051351 | positive regulation of ligase activity | 9242410 | GO:0006302 | double-strand break repair | 9242410 | GO:0006303 | double-strand break repair via nonhomologous end joining | 12517771 | GO:0010165 | response to X-ray | 9242410 | GO:0051103 | DNA ligation involved in DNA repair | 12517771 | GO:0051351 | positive regulation of ligase activity | 9242410 |
Top |
TissGeneExp for XRCC4 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for XRCC4 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for XRCC4 |
TissGeneSNV for XRCC4 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.M319T | THYM | 1 |
p.L10F | SKCM | 1 |
p.L152P | STAD | 1 |
p.M61T | COAD | 1 |
p.H195R | LIHC | 1 |
p.K146N | LIHC | 1 |
p.L319S | LUAD | 1 |
p.R225Q | BLCA | 1 |
p.R275Q | BRCA | 1 |
p.P14A | SKCM | 1 |
p.S248L | BLCA | 1 |
p.Q289H | STAD | 1 |
p.R7I | UCEC | 1 |
p.D230N | BRCA | 1 |
p.L144P | COAD | 1 |
p.D157N | BLCA | 1 |
p.A60T | UCEC | 1 |
p.F86L | UCEC | 1 |
p.I16K | STAD | 1 |
p.G109V | LUAD | 1 |
p.E125X | READ | 1 |
p.R272S | BLCA | 1 |
p.E220Q | BRCA | 1 |
p.R179W | KICH | 1 |
p.W24S | HNSC | 1 |
p.S303Y | COAD | 1 |
p.S53F | SKCM | 1 |
p.Q289H | LUAD | 1 |
p.N141T | HNSC | 1 |
p.S12C | DLBC | 1 |
p.R275X | THYM | 1 |
p.H143R | STAD | 1 |
p.L36P | UCEC | 1 |
Top |
TissGeneCNV for XRCC4 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for XRCC4 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BG282107 | TPD52L2-XRCC4 | chr20:62522725 | chr5:82648950 | |
TCGAfusionPortal | PRADA | LUSC | TCGA-43-3920-01A | COL4A5-XRCC4 | Out-of-frame | ChrX:107683436 | Chr5:82648944 |
Top |
TissGeneNet for XRCC4 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for XRCC4 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for XRCC4 |
TissGeneDrug for XRCC4 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for XRCC4 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0006142 | Malignant neoplasm of breast | 12 | BeFree,GAD |
umls:C0596263 | Carcinogenesis | 11 | BeFree |
umls:C0678222 | Breast Carcinoma | 10 | BeFree |
umls:C0005684 | Malignant neoplasm of urinary bladder | 6 | BeFree,GAD |
umls:C0017638 | Glioma | 5 | BeFree,GAD |
umls:C0242379 | Malignant neoplasm of lung | 5 | BeFree,GAD |
umls:C0026640 | Mouth Neoplasms | 4 | GAD,LHGDN |
umls:C0153381 | Malignant neoplasm of mouth | 4 | BeFree |
umls:C0220641 | Lip and Oral Cavity Carcinoma | 4 | BeFree |
umls:C0006118 | Brain Neoplasms | 3 | GAD |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 3 | BeFree |
umls:C0013336 | Dwarfism | 3 | BeFree |
umls:C0026764 | Multiple Myeloma | 3 | BeFree,GAD |
umls:C0038356 | Stomach Neoplasms | 3 | GAD,LHGDN |
umls:C0376358 | Malignant neoplasm of prostate | 3 | BeFree,GAD |
umls:C0699885 | Carcinoma of bladder | 3 | BeFree |
umls:C2239176 | Liver carcinoma | 3 | BeFree |
umls:C0007137 | Squamous cell carcinoma | 2 | GAD |
umls:C0008626 | Congenital chromosomal disease | 2 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 2 | BeFree |
umls:C0023418 | leukemia | 2 | BeFree,GAD |
umls:C0024299 | Lymphoma | 2 | BeFree |
umls:C0024301 | Lymphoma, Follicular | 2 | BeFree,GAD |
umls:C0040136 | Thyroid Neoplasm | 2 | GAD |
umls:C0342573 | PITUITARY DWARFISM I | 2 | BeFree,CLINVAR |
umls:C0600139 | Prostate carcinoma | 2 | BeFree |
umls:C0684249 | Carcinoma of lung | 2 | BeFree |
umls:C1458155 | Mammary Neoplasms | 2 | GAD,LHGDN |
umls:C1527249 | Colorectal Cancer | 2 | BeFree,GAD |
umls:C0001418 | Adenocarcinoma | 1 | BeFree,GAD |
umls:C0001486 | Adenovirus Infections | 1 | BeFree |
umls:C0001973 | Alcoholic Intoxication, Chronic | 1 | BeFree |
umls:C0003873 | Rheumatoid Arthritis | 1 | BeFree |
umls:C0007133 | Carcinoma, Papillary | 1 | GAD |
umls:C0007134 | Renal Cell Carcinoma | 1 | LHGDN |
umls:C0008625 | Chromosome Aberrations | 1 | CTD_human |
umls:C0009404 | Colorectal Neoplasms | 1 | GAD |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | GAD |
umls:C0012860 | DNA Damage | 1 | GAD |
umls:C0014175 | Endometriosis | 1 | BeFree,GAD,LHGDN |
umls:C0015544 | Failure to Thrive | 1 | BeFree |
umls:C0015625 | Fanconi Anemia | 1 | BeFree |
umls:C0020538 | Hypertensive disease | 1 | GWASCAT |
umls:C0023267 | Fibroid Tumor | 1 | BeFree,GAD |
umls:C0023434 | Chronic Lymphocytic Leukemia | 1 | GAD |
umls:C0023895 | Liver diseases | 1 | BeFree |
umls:C0024117 | Chronic Obstructive Airway Disease | 1 | GAD |
umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | BeFree,GAD |
umls:C0024623 | Malignant neoplasm of stomach | 1 | BeFree,GAD |
umls:C0025284 | Meningeal Neoplasms | 1 | GAD |
umls:C0025286 | Meningioma | 1 | GAD |
umls:C0026769 | Multiple Sclerosis | 1 | GAD |
umls:C0027086 | Myoma | 1 | BeFree |
umls:C0027819 | Neuroblastoma | 1 | BeFree |
umls:C0027859 | Acoustic Neuroma | 1 | GAD |
umls:C0032927 | Precancerous Conditions | 1 | GAD |
umls:C0036341 | Schizophrenia | 1 | BeFree,GAD |
umls:C0036421 | Systemic Scleroderma | 1 | BeFree |
umls:C0039101 | synovial sarcoma | 1 | BeFree |
umls:C0042133 | Uterine Fibroids | 1 | BeFree |
umls:C0079744 | Diffuse Large B-Cell Lymphoma | 1 | GAD |
umls:C0079745 | Lymphoma, Large-Cell, Follicular | 1 | BeFree |
umls:C0085110 | Severe Combined Immunodeficiency | 1 | BeFree |
umls:C0268138 | Xeroderma Pigmentosum, Complementation Group D | 1 | BeFree |
umls:C0268615 | 5,10-Methylenetetrahydrofolate reductase deficiency | 1 | BeFree |
umls:C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 1 | BeFree |
umls:C0345904 | Malignant neoplasm of liver | 1 | BeFree |
umls:C0518010 | body mass | 1 | GAD |
umls:C0524620 | Metabolic Syndrome X | 1 | BeFree |
umls:C0677886 | Epithelial ovarian cancer | 1 | GAD |
umls:C0699791 | Stomach Carcinoma | 1 | BeFree |
umls:C0850666 | Helicobacter pylori infection | 1 | BeFree |
umls:C0878787 | Growth failure | 1 | BeFree |
umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 1 | BeFree |
umls:C3539878 | Triple Negative Breast Neoplasms | 1 | BeFree |